Team Details

Kabeer is a co-founder and Principal at Adjuvant Capital, a life sciences investment firm focused on high-burden and neglected public health challenges. Prior to Adjuvant, Kabeer was with the Global Health Investment Fund (GHIF), where he led investments in biotech companies addressing unmet needs in infectious disease and maternal & child health. Before GHIF, Kabeer spent time at Metalmark Capital investing across the healthcare sector, as well as Greenhill & Co., where he advised on biopharmaceutical M&A transactions. He graduated with honors from the Stern School of Business at New York University.